LYNN CAHILL-HOY: Open Payments
NPI 1811976160 · CAMILLUS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 19 payments from 11 companies in 2025. Trend: 2023 $353 · 2024 $345 · 2025 $357
Food & beverage: $314Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $67 |
| Lilly USA, LLC | 4 | $67 |
| Mannkind Corporation | 2 | $60 |
| Exact Sciences Corporation | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Insulet Corporation | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: MOUNJARO, AFREZZA, Ozempic, The Cologuard Plus Collection Kit, Kerendia, Omnipod, UNITHROID, JARDIANCE.
Industry payments across NY — which companies pay providers there.
